The diagnostics of colorectal cancer

@article{widerska2014TheDO,
  title={The diagnostics of colorectal cancer},
  author={M. Świderska and B. Choromanska and E. Dąbrowska and E. Konarzewska-Duchnowska and Katarzyna Choromańska and Grzegorz Szczurko and P. Myśliwiec and J. Dadan and J. Ładny and K. Zwierz},
  journal={Contemporary Oncology},
  year={2014},
  volume={18},
  pages={1 - 6}
}
  • M. Świderska, B. Choromanska, +7 authors K. Zwierz
  • Published 2014
  • Medicine
  • Contemporary Oncology
  • Colorectal cancer (CRC) is one of the most frequent human malignant neoplasms. CRC has an estimated incidence of more than 1,000,000 new cases annually worldwide. Approximately one out of three people who develop CRC dies from the disease. Furthermore, CRC often affects inhabitants of industrialized countries in comparison to less developed countries. Several markers of colon cancer, including CEA, CA-19-9, TPS, TAG-72 and lysosomal hydrolases, have been identified and are now being adopted in… CONTINUE READING
    54 Citations
    Biochemical Markers of Colorectal Cancer – Present and Future
    • 2
    • PDF
    Vaccines for colorectal cancer: an update
    • 7
    Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
    • 28
    • Highly Influenced
    • PDF
    Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
    • 1
    The potential of exosomes derived from colorectal cancer as a biomarker.
    • Y. Xiao, Y. Li, +7 authors L. Jia
    • Medicine
    • Clinica chimica acta; international journal of clinical chemistry
    • 2019
    • 17

    References

    SHOWING 1-10 OF 60 REFERENCES
    Biomarkers for Colorectal Cancer
    • 110
    • PDF
    Molecular detection of colorectal neoplasia.
    • 123
    Epigenetic Biomarkers in Colorectal Cancer
    • 37
    Carbohydrate Markers in Colon Carcinoma
    • 27
    • PDF
    Epigenetic biomarkers in colorectal cancer diagnostics
    • 43
    Initial TPS serum level as an indicator of relapse and survival in colorectal cancer.
    • 16